Physician profile
Mark Trombetta
NPI 1073515789
$1,548.22
in general payments reported to CMS, 2019-2025
24 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $77.14 · 2021: $155 · 2022: $193 · 2023: $96.07 · 2024: $138 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $573.37 | 2019-2022 | |
| Astellas Pharma US INC | $144.74 | 2019-2025 | Xtandi, Vyloy |
| Genentech USA, INC. | $111.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.12 | 2023-2025 | |
| Myovant Sciences INC. | $71.79 | 2021-2022 | |
| Carl Zeiss Meditec USA, INC. | $69.46 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $54.17 | 2022-2025 | Libtayo |
| Emd Serono, INC. | $43.28 | 2024-2025 | |
| Incyte Corporation | $43.01 | 2025 | Monjuvi, Zynyz, Jakafi |
| E.R. Squibb & Sons, L.L.C. | $37.01 | 2019-2022 | |
| Exelixis INC. | $31.23 | 2019-2025 | Cabometyx |
| Abbvie INC. | $29.42 | 2025 | |
| Acrotech Biopharma INC. | $27.48 | 2025 | Beleodaq |
| Astrazeneca Pharmaceuticals Lp | $27.40 | 2025 | |
| Lilly USA, LLC | $22.73 | 2024 | Jaypirca, Verzenio, Retevmo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Morphosys, US INC. | $22.45 | 2023 | Monjuvi |
| Seagen INC. | $21.98 | 2023 | Padcev |
| Merck Sharp & Dohme LLC | $19.75 | 2025 | Keytruda |
| Eisai INC. | $18.87 | 2023 | |
| Medtronic USA, INC. | $18.85 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.70 | 2020 | |
| Foundation Medicine, INC. | $15.41 | 2020 | |
| Boston Scientific Corporation | $12.88 | 2023 | Rezum Generator |
| Tesaro, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Trombetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.